The Global Smart Medical Devices Market is estimated to be valued at USD 52,736.23 million in 2024 and is projected to reach USD 131,331.58 million by 2032, growing at a CAGR of 12.20% during the forecast period from 2025 to 2032.
The market growth is driven by the rising global burden of chronic diseases, an aging population requiring continuous health monitoring, and rapid advancements in Artificial Intelligence (AI), the Internet of Things (IoT), 5G connectivity, remote patient monitoring, and connected healthcare technologies.
DelveInsight’s Smart Medical Devices Market Insights Report 2032 provides a comprehensive assessment of the market, including market size, forecasts, market shares, key market drivers and barriers, emerging trends, competitive landscape, company profiles, and strategic developments.
Read more about the Smart Medical Devices Market:
https://www.delveinsight.com/report-store/smart-medical-devices-market?utm_source=pngw&utm_medium=pressrelease&utm_campaign=mpr
Key Takeaways from the Smart Medical Devices Market Report
- In September 2025, B. Braun acquired True Digital Surgery, a company specializing in digital robotic-assisted 3D surgical microscopy. The acquisition reinforces B. Braun’s focus on digital microsurgery and strengthens its smart-device surgical portfolio.
- In May 2025, Masimo Corporation received FDA 510(k) clearance for its Masimo W1 watch, expanding its indications to include continuous and spot-check heart rate and oxygen saturation (SpO2) measurements. This development strengthens the role of wearable devices in clinical-grade, multi-parameter monitoring.
- In April 2025, WHOOP, Inc. received FDA clearance for its WHOOP ECG feature, enabling single-lead electrocardiogram readings and notifications for heart-rhythm irregularities. This represents an important step in the transition of consumer-grade wearables toward medical-grade diagnostics.
- The global Smart Medical Devices Market is projected to grow at a CAGR of 12.20% from 2025 to 2032.
- Key market growth factors include the increasing prevalence of chronic diseases, population aging, technological advancements in AI and IoT, expanding 5G infrastructure, and the growing adoption of remote patient monitoring and home-based healthcare.
Leading Smart Medical Devices Companies
The major companies operating in the Smart Medical Devices Market include:
Siemens Healthineers, Stryker, Samsung Electronics Co., Ltd., GE HealthCare, Koninklijke Philips N.V., Medtronic, Abbott Laboratories, Dexcom, Inc., Boston Scientific Corporation, OMRON Corporation, Apple Inc., B. Braun, iRhythm Technologies, Inc., Fresenius Kabi AG, Vital Connect, Inc., Masimo Corporation, Insulet Corporation, Zoll Medical Corporation, ResMed, F. Hoffmann-La Roche Ltd., Ypsomed, and others.
Explore the Smart Medical Devices Market:
https://www.delveinsight.com/report-store/smart-medical-devices-market?utm_source=pngw&utm_medium=pressrelease&utm_campaign=mpr
Smart Medical Devices Market Overview
Smart medical devices represent a rapidly evolving category of connected healthcare technologies and form an important component of the Internet of Medical Things (IoMT). These devices combine sensors, wireless connectivity, AI-powered analytics, cloud technologies, and healthcare-system interoperability to support more proactive, personalized, and efficient patient care.
Unlike conventional standalone medical equipment, smart medical devices can collect, transmit, analyze, and interpret health data in real time. They are increasingly being used across diagnostics, patient monitoring, therapeutics, remote patient monitoring, home healthcare, and preventive care.
Smart Medical Devices Market Key Growth Drivers
Rising Burden of Chronic Diseases
The increasing prevalence of chronic diseases is one of the primary factors driving demand for smart medical devices. Diabetes, hypertension, cardiovascular diseases, and sleep-related disorders require continuous monitoring and long-term disease management.
According to estimates cited by DelveInsight, approximately 589 million adults were living with diabetes in 2024, with the number projected to reach 853 million by 2050. In addition, around 1.3 billion people globally live with hypertension, creating significant demand for connected monitoring and diagnostic solutions.
Growing Prevalence of Cardiovascular and Sleep Disorders
The increasing prevalence of cardiovascular and sleep-related conditions is further supporting market expansion. An estimated 53–59 million people worldwide live with atrial fibrillation, while up to 936 million adults are affected by obstructive sleep apnea, many of whom remain undiagnosed.
Smart ECG devices, wearable monitors, pulse oximeters, sleep-monitoring devices, and connected diagnostic technologies are helping healthcare providers detect and manage these conditions more efficiently.
Expansion of 5G and Connected Healthcare
The expansion of high-speed connectivity is accelerating the adoption of connected medical technologies. According to GSMA, nearly one-third of global mobile connections were expected to be 5G by 2025, supporting the large-scale implementation of real-time remote patient monitoring.
In the United States, the remote patient monitoring user base was projected to exceed 71 million people, representing approximately 26% of the population by 2025.
Product Innovation and Wearable Technology
Continuous innovation is expanding the range of smart medical devices available to patients and healthcare providers. Examples include:
- Long-duration continuous glucose monitoring systems
- Clinical-grade wearable ECG patches
- Smartwatches with ECG and SpO2 capabilities
- AI-enabled diagnostic and imaging systems
- Smart insulin pumps
- Connected neurostimulators
- Remote patient monitoring platforms
Products such as Abbott’s FreeStyle Libre 2 Plus and Dexcom’s G7 Continuous Glucose Monitoring (CGM) system illustrate the growing adoption of connected monitoring technologies.
Increasing Adoption of AI and Machine Learning
AI and machine learning are transforming raw sensor data into actionable clinical insights. AI-enabled systems can help identify early indicators of conditions such as atrial fibrillation, predict potential hypoglycemic episodes, improve surgical precision, and support adaptive therapeutic technologies.
The integration of AI is expected to remain a major differentiating factor as manufacturers compete to develop more intelligent, predictive, and personalized medical devices.
Strategic Partnerships and M&A Activity
Strategic collaborations, acquisitions, and technology partnerships are also shaping the competitive landscape. For example, B. Braun’s acquisition of True Digital Surgery strengthens its position in digital microsurgery, while Medtronic’s collaboration with NVIDIA highlights the growing importance of AI-assisted surgical technologies.
Get a snapshot of the Smart Medical Devices Market Dynamics:
https://www.delveinsight.com/report-store/smart-medical-devices-market?utm_source=pngw&utm_medium=pressrelease&utm_campaign=mpr
Smart Medical Devices Market Segment Analysis
The Smart Medical Devices Market can be segmented based on:
- Device Type: Diagnostic & Monitoring Devices and Therapeutic Devices
- Product Type: Wearables, Implantables, Portable/Point-of-Care Devices, Stationary/Bedside Devices, and Others
- Application: General Health and Fitness, Remote Patient Monitoring, Diagnostics, Therapeutics, and Home Healthcare
- End User: Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Home Healthcare, and Others
- Geography: North America, Europe, Asia-Pacific, and Rest of World
By Device Type
Diagnostic and monitoring devices accounted for approximately 65% of the market share in 2024. Their dominance is supported by the widespread adoption of wearable monitoring technologies, continuous glucose monitors, wearable ECG patches, pulse oximeters, and remote patient monitoring systems.
By Product Type
Wearables represented the largest product segment, accounting for nearly 47% of the market in 2024. Growth is supported by widespread consumer adoption and the integration of medical-grade ECG, SpO2, heart-rate, and other health-monitoring capabilities into smartwatches and wearable devices.
By End User
Hospitals and clinics represented the leading end-user segment, accounting for an estimated 43% share in 2024. Their dominance is attributed to advanced healthcare infrastructure, greater access to technology and capital, EHR integration capabilities, and the need to manage complex chronic conditions.
Explore the Smart Medical Devices Market trends and competitive landscape:
https://www.delveinsight.com/report-store/smart-medical-devices-market?utm_source=pngw&utm_medium=pressrelease&utm_campaign=mpr
Smart Medical Devices Market Competitive Landscape
The Smart Medical Devices Market is characterized by a moderately concentrated competitive environment, with established medical technology companies competing alongside technology companies and emerging startups.
Leading players such as Medtronic, Abbott Laboratories, and Johnson & Johnson maintain strong positions through extensive product portfolios, significant R&D investments, established regulatory capabilities, and global commercial networks.
Technology-focused companies such as Apple and Samsung are strengthening their presence in wearable diagnostics and connected health monitoring by leveraging their expertise in consumer electronics and digital technologies.
At the same time, emerging companies such as Butterfly Network, Biofourmis, and Eko Health are contributing to innovation in software-enabled medical devices, AI-powered diagnostics, digital health platforms, and specialized monitoring applications.
Smart Medical Devices Companies
The leading companies operating in the Smart Medical Devices Market include:
- Siemens Healthineers
- Stryker
- Samsung Electronics Co., Ltd.
- GE HealthCare
- Koninklijke Philips N.V.
- Medtronic
- Abbott Laboratories
- Dexcom, Inc.
- Boston Scientific Corporation
- OMRON Corporation
- Apple Inc.
- B. Braun
- iRhythm Technologies, Inc.
- Fresenius Kabi AG
- Vital Connect, Inc.
- Masimo Corporation
- Insulet Corporation
- Zoll Medical Corporation
- ResMed
- F. Hoffmann-La Roche Ltd.
- Ypsomed
- and others
Smart Medical Devices Market Restraints
Despite strong growth prospects, several challenges could limit the adoption of smart medical devices.
Data Privacy and Cybersecurity Risks
Smart medical devices collect and transmit highly sensitive patient information, making them potential targets for cyberattacks. Concerns regarding data privacy, cybersecurity, and the absence of harmonized global health-data governance may affect consumer and healthcare-provider confidence.
High Device Costs and Reimbursement Challenges
Clinical-grade smart devices can be expensive, particularly advanced implantable, monitoring, and therapeutic technologies. Inconsistent reimbursement policies across countries can also limit accessibility and adoption.
Device Accuracy and Reliability
Sensor accuracy may be affected by factors such as motion artifacts, skin characteristics, environmental conditions, and signal interference. Battery-life limitations can also affect the usability and compliance of continuously worn or remotely connected devices.
Regulatory Fragmentation
Differences in regulatory requirements, approval timelines, interoperability standards, and data regulations across markets can increase development costs and delay commercialization.
Tariff and Supply Chain Pressures
Changes in international trade policies and tariffs may increase manufacturing and supply-chain costs. Companies are therefore exploring sourcing diversification, supply-chain restructuring, and localized manufacturing strategies to manage these pressures.
Interested in understanding where the Smart Medical Devices Market: https://www.delveinsight.com/report-store/smart-medical-devices-market?utm_source=pngw&utm_medium=pressrelease&utm_campaign=mpr
Scope of the Smart Medical Devices
- Market: Smart Medical Devices Market
- Geographic Coverage: Global
- Forecast Period: 2025–2032
- Base Year: 2024
- Market Size (2024): USD 52,736.23 million
- Projected Market Size (2032): USD 131,331.58 million
- CAGR: 12.20%
- Key Companies: Siemens Healthineers, Stryker, Samsung Electronics, GE HealthCare, Koninklijke Philips, Medtronic, Abbott Laboratories, Dexcom, Boston Scientific, OMRON, Apple, B. Braun, iRhythm Technologies, Fresenius Kabi, Vital Connect, Masimo, Insulet, Zoll Medical, ResMed, F. Hoffmann-La Roche, Ypsomed, and others.
- Key Analysis: Market Drivers, Market Restraints, Market Trends, Regulatory Analysis, Competitive Landscape, Porter’s Five Forces Analysis, Market Assessment, Startup Funding & Investment Trends.
Table of Contents
- Smart Medical Devices Market Report Introduction
- Smart Medical Devices Market Executive Summary
- Smart Medical Devices Market Key Factors Analysis
- Impact Analysis
- Regulatory Analysis
- Smart Medical Devices Market Porter’s Five Forces Analysis
- Smart Medical Devices Market Assessment
- Competitive Landscape
- Startup Funding & Investment Trends
- Smart Medical Devices Market Company and Product Profiles
- KOL Views
- Project Approach
- About DelveInsight
- Disclaimer & Contact Us
About DelveInsight
DelveInsight is a healthcare-focused market research and consulting firm providing market intelligence and strategic insights to support informed business decisions across the pharmaceutical, biotechnology, medical device, and healthcare industries.
With experienced industry professionals and expertise across the global life sciences sector, DelveInsight provides customized research solutions designed to help organizations understand market dynamics, evaluate competitive environments, identify growth opportunities, and make data-driven strategic decisions.
